🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
Fat/Fatty Acid Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

1000 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1000mg UL 3000mg

Other Ingredients

Vitamin E Gelatin Glycerin

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Recommended Use: Helps maintain healthy heart and brain function. Recommended Dose (Adults): Take 2 softgels daily.

⚠️ Warnings & Precautions

DO NOT USE IF SEAL UNDER CAP IS BROKEN.

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

This product does not contain corn, dairy, egg, gluten, shellfish, sulfites, wheat or artificial colours, flavours, or preservatives.

Omega-3 Fatty Acids 18% EPA and 12% DHA

Additional Information

A Proud Canadian Company

UPC CODE TO BE: 0 63047 40074 5

{Softgel} Actual Size

400740.01-05

SunOpta A healthy products company

This product has been tested and meets international standards for levels of arsenic, cadmium, lead, mercury, pesticides and solvent residues.

STORE IN A COOL, DRY PLACE.

Helps Maintain Healthy Heart and Brain Function

Product Details

DSLD Entry Date 2013-05-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 21972
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →